232 related articles for article (PubMed ID: 17227437)
1. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
Wiesinger JA; Buwen JP; Cifelli CJ; Unger EL; Jones BC; Beard JL
J Neurochem; 2007 Jan; 100(1):167-79. PubMed ID: 17227437
[TBL] [Abstract][Full Text] [Related]
2. Cellular iron concentrations directly affect the expression levels of norepinephrine transporter in PC12 cells and rat brain tissue.
Beard JL; Wiesinger JA; Jones BC
Brain Res; 2006 May; 1092(1):47-58. PubMed ID: 16650837
[TBL] [Abstract][Full Text] [Related]
3. Iron chelation down-regulates dopamine transporter expression by decreasing mRNA stability and increasing endocytosis in N2a cells.
Hegde NV; Jensen GL; Unger EL
Exp Cell Res; 2011 Feb; 317(4):405-12. PubMed ID: 21147099
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
5. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation.
Gorentla BK; Vaughan RA
Neuropharmacology; 2005 Nov; 49(6):759-68. PubMed ID: 16181646
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of dopamine transporter trafficking and function after abstinence from cocaine self-administration in rats: evidence for differential regulation in caudate putamen and nucleus accumbens.
Samuvel DJ; Jayanthi LD; Manohar S; Kaliyaperumal K; See RE; Ramamoorthy S
J Pharmacol Exp Ther; 2008 Apr; 325(1):293-301. PubMed ID: 18198344
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin gallate regulates dopamine transporter internalization via protein kinase C-dependent pathway.
Li R; Peng N; Li XP; Le WD
Brain Res; 2006 Jun; 1097(1):85-9. PubMed ID: 16733047
[TBL] [Abstract][Full Text] [Related]
9. Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner.
Pifl C; Wolf A; Rebernik P; Reither H; Berger ML
Neuropharmacology; 2009 Feb; 56(2):531-40. PubMed ID: 19000913
[TBL] [Abstract][Full Text] [Related]
10. Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats.
Bianco LE; Wiesinger J; Earley CJ; Jones BC; Beard JL
J Neurochem; 2008 Jul; 106(1):205-15. PubMed ID: 18363828
[TBL] [Abstract][Full Text] [Related]
11. The dopamine transporter is differentially regulated after dopaminergic lesion.
Afonso-Oramas D; Cruz-Muros I; Barroso-Chinea P; Álvarez de la Rosa D; Castro-Hernández J; Salas-Hernández J; Giráldez T; González-Hernández T
Neurobiol Dis; 2010 Dec; 40(3):518-30. PubMed ID: 20688165
[TBL] [Abstract][Full Text] [Related]
12. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
Wersinger C; Vernier P; Sidhu A
Biochemistry; 2004 Feb; 43(5):1242-53. PubMed ID: 14756560
[TBL] [Abstract][Full Text] [Related]
13. Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells.
Chen N; Reith ME
J Neurochem; 2007 Apr; 101(2):377-88. PubMed ID: 17250655
[TBL] [Abstract][Full Text] [Related]
14. Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism.
Sorkina T; Hoover BR; Zahniser NR; Sorkin A
Traffic; 2005 Feb; 6(2):157-70. PubMed ID: 15634215
[TBL] [Abstract][Full Text] [Related]
15. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells.
Kantor L; Hewlett GH; Park YH; Richardson-Burns SM; Mellon MJ; Gnegy ME
J Pharmacol Exp Ther; 2001 Jun; 297(3):1016-24. PubMed ID: 11356924
[TBL] [Abstract][Full Text] [Related]
17. Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations.
Chi L; Reith ME
J Pharmacol Exp Ther; 2003 Nov; 307(2):729-36. PubMed ID: 12975490
[TBL] [Abstract][Full Text] [Related]
18. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
[TBL] [Abstract][Full Text] [Related]
19. Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells.
Wang J; Michelhaugh SK; Bannon MJ
Eur J Neurosci; 2007 Apr; 25(7):1982-6. PubMed ID: 17439486
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter.
Wersinger C; Sidhu A
Biochemistry; 2005 Oct; 44(41):13612-24. PubMed ID: 16216085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
